BRCA1 Germ-line Mutations and Tumor Characteristics in Eastern Chinese Women with Familial Breast Ca

来源 :第五届浙江省胸部肿瘤论坛暨长三角专家峰会 | 被引量 : 0次 | 上传用户:wtmw
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Although several studies detected the BRCA1 germ-line mutations in Chinese women with familial breast cancer, most of them did not employed conventional full gene sequencing, especially in eastern China. In this study, we screened the complete coding regions and exon-intron boundaries of BR-CA1 by polymerase chain reaction (PCR)-sequencing assay. One hundred and twenty breast cancer patients having one or more affected relatives referred from the Zhejiang Cancer Hospital, eastern China during 2008~2011 were selected for the study. A total of 62 familial breast cancer patients received the BRCA1 germ-line mutation screening. Five deleterious mutations were detected in this cohort. The mutation rate was 11.3% (7/62). We found 2 novel mutations (3414delC and 5280 C>T) and 2 recurrent mutations (5273 G>A and 5589del8). BRCA1 mutation tumors tended to be negative for ER, PR and HER-2, and exhibited high histological grade compared with tumors without BRCA1 mutations. Our study suggests that recurrent mutations may exist in eastern Chinese women with familial breast cancer and PCR-se-quencing assay is a useful tool to screen these mutations. The study also suggests that BRCA1-associated breast cancer in Chinese women exhibit an aggressive phenotype.
其他文献
[目的]讨论谷胱甘肽硫基转移酶P1(gutathione S-transferase pi1,GSTP1)基因Ile105Val(rs1695)单核苷酸多态性(single nucleotide polymorphism,SNP)与非小细胞肺癌化学敏感性、消化道和血液学毒性反应及生存的关系。  [方法]采用TaqMan基因型分析技术检测100例晚期非小细胞肺癌患者外周血白细胞中GSTP1 I1e1
[背景与目的]随着高效低度药物的出现越来越多的晚期非小细胞肺癌(non-small cell lung cancer,NSCLC)患者有机会接受三线治疗,但目前三线的标准治疗除厄洛替尼外尚无其它选择方案.本研究旨在比较单药化疗、靶向药物与双药联合化疗在晚期NSCLC患者三线治疗中的疗效与安全性。  [方法]回顾分析115例Ⅲb期/Ⅳ期接受三线治疗的NSCLC患者的疗效及生存状况。采用Kaplan-
[目的]比较复治晚期非小细胞肺癌(non-small cell lung cancer,NSCLC)表皮生长因子受体-酪氨酸激酶抑制剂(epidermal growth factor receptor-tyrosine kinase inhibitor,EGFR—TKI)治疗失败后用培美曲塞与多西他赛挽救性化疗疗效及毒副反应。  [方法]回顾性分析我院120例复治晚期NSCLC患者。EGFR—TK
肺癌是严重威胁人民健康的重大疾病之一,由于缺乏可靠的早期诊断方法及有效的晚期治疗手段,自1970年至今其生存率一直没有较大的提高,长期居于癌症死亡病因的首位。而对于有可靠的早期筛查方法的乳腺癌、结肠癌及前列腺癌来说,其5年生存率可达肺癌的4-6倍。所以,探索肺癌的早期诊断方法具有至关重要的意义。而肺癌的肿瘤标志物研究以其无创、可重复性强等特点,在科研及临床上具有着独特的优势。本文旨在对肺癌相关肿瘤
[目的]分析索拉非尼联合经导管肝动脉化疗栓塞(transcatheter arterial chemoembolization,TACE)治疗肝细胞癌(hepatocelllular carcinoma,HCC)多发肺转移的疗效.  [方法]15例伴有多发肺转移的晚期HCC患者,肝脏原发肿瘤经导管肝动脉化疗栓塞(transcatheter-arterial chemoembolization,TA
BACKGROUND: Prophylactic cranial irradiation (PCI) has been considered standard treatment in patients with limited-stage small cell lung cancer(LS-SCLC) in complete remission following systemic therap
[Introduction] This study aims to compare treatment outcomes between stereotactic body radiation therapy (SBRT) and surgery in early-stage non-small-cell lung cancer (NSCLC). [Methods] Eligible studie
会议
Background:Pancreatic cancer survival continues to be amongst the shortest of all cancers, and new therapies are urgently needed. In this study, we sought to identify the potential therapeutic effects
胃癌是严重危害人类健康的常见恶性肿瘤之一。在胃癌中,ErbB2致癌基因的扩增或过度表达是导致其不良预后的一个独立的影响因素。人表皮生长因子受体2 (human epidermal growth factor re-ceptor 2,HER-2/neu)基因是一种原癌基因。体内外研究证实HER-2癌基因也是肿瘤转移驱动因子,即HER-2过度表达的恶性肿瘤具有更强的侵袭、转移能力,预后较差。在日本晚期
会议